Product Approvals and Partnerships were the Key Growth Strategies Adopted by Players in the Gas Chromatography Market

According to the new market research report "Gas Chromatography Market by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators),End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) - Global Forecast to 2022", published by MarketsandMarkets™, The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%. 


In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.
On the basis of accessories and consumables, the market is segmented into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is expected to be the fastest-growing of the global gas chromatography market during the forecast period. The growth of this segment can primarily be attributed to factors such as discovery of new oil fields and the availability of improved gas chromatography columns for the petroleum industry.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest market share in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growing food testing industries are driving the growth of the North American gas chromatography market.
Gas Chromatography Market


Key players in this market include Agilent Technologies, Inc. (U.S), Thermo Fisher Scientific, Inc. (U.S), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S), Danaher Corporation (U.S), Scion instruments (Techcomp USA Inc.), Leco corporation (U.S), Merck KgaA (Germany), Falcon Analytical Systems &Technology, LLC (U.S), Restek Corporation (U.S), Dani Instruments S.P.A. (Italy) and Chromatotec (France). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Location: Dundee Rd, Illinois, USA

Comments

Post a Comment

Popular posts from this blog

Key Players in the Pyrogen Testing Market Focus on Partnerships, Agreements, & Collaborations, Acquisitions, New Product launches, and Expansions

Image
The report  " Pyrogen Testing Market  by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021 " ,  report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis. Speak to Analyst @  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255266155 The global pyrogen testing market is valued at $462.38 million in 2014 and is expected to grow at a CAGR of 12.23%, to reach $823.14 million by 2019. Pyrogen testing is used to determine the bacterial toxins in products intended for medical or veterinary use. Rapidly growing pharmaceutical and biotechnology industries are a major growth driver for this market. Further
Read more

Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Application and End User

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT. Based on application
Read more

Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

Image
The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.). The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%. The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).
Read more